Qube Research & Technologies (QRT)
DRTS icon

Qube Research & Technologies (QRT)’s Alpha Tau Medical DRTS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24
Closed -$61 – 3490
2024
Q2 		$61 Hold
24
– – ﹤0.01% 3480
2024
Q1 		$71 Hold
24
– – ﹤0.01% 4199
2023
Q4 		$72 Hold
24
– – ﹤0.01% 4046
2023
Q3 		$91 Buy
+24
New +$88 ﹤0.01% 3772

Other funds holding DRTS

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DRTS Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Alpha Tau Medical (DRTS) in Q3 2024, closing a stake of 24 shares — an estimated $61 sold.

Qube Research & Technologies (QRT) first reported a position in DRTS in Q3 2023 and held it in 4 quarters. The position peaked at $91 in Q3 2023. 23 funds tracked by Wall St. Rank hold DRTS as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Alpha Tau Medical position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 24 Alpha Tau Medical shares in Q3 2024, an estimated $61.
  • Qube Research & Technologies (QRT) first reported a position in Alpha Tau Medical in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Alpha Tau Medical position peaked at $91 in Q3 2023.
  • 23 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.